Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
April 10, 1971
Isolation from the mushroom Agaricus bisporus and chemical synthesis of gamma-L-glutaminyl-4-hydroxybenzene
R F Weaver, K V Rajagopalan, P Handler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1970
Isolation of -L-glutaminyl 4-hydroxybenzene and -L-glutaminyl 3,4-benzoquinone: a natural sulfhydryl reagent, from sporulating gill tissue of the mushroom Agaricus bisporus
R F Weaver, K V Rajagopalan, P Handler, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1
Logan M Morrison, Haoran Huang, Hillary P Handler, et al.
Human Molecular Genetics
|
October 30, 2024
Increased intrinsic membrane excitability is associated with olivary hypertrophy in spinocerebellar ataxia type 1
Logan M Morrison, Haoran Huang, Hillary P Handler, et al.
Neurobiology of Disease
|
February 1, 2023
BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1
Juao-Guilherme Rosa, Katherine Hamel, Alyssa Soles, et al.
Cells
|
October 27, 2022
Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice
Juao-Guilherme Rosa, Katherine Hamel, Carrie Sheeler, et al.
Human Molecular Genetics
|
September 23, 2020
Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1
Ravi Chopra, David D Bushart, John P Cooper, et al.
Molecular Therapy. Nucleic Acids
|
August 21, 2020
Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment
Brennon O'Callaghan, Bente Hofstra, Hillary P Handler, et al.
Cancer Research
|
June 24, 2026
Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer
Matthew A Clarke, Charlie George Barker, Ashley Nicholls, et al.
Frontiers in Genetics
|
May 19, 2025
Validation of a comprehensive long-read sequencing platform for broad clinical genetic diagnosis
Siddhartha Sen, Hillary P Handler, Alec Victorsen, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
April 10, 1971
Isolation from the mushroom Agaricus bisporus and chemical synthesis of gamma-L-glutaminyl-4-hydroxybenzene
R F Weaver, K V Rajagopalan, P Handler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1970
Isolation of -L-glutaminyl 4-hydroxybenzene and -L-glutaminyl 3,4-benzoquinone: a natural sulfhydryl reagent, from sporulating gill tissue of the mushroom Agaricus bisporus
R F Weaver, K V Rajagopalan, P Handler, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1
Logan M Morrison, Haoran Huang, Hillary P Handler, et al.
Human Molecular Genetics
|
October 30, 2024
Increased intrinsic membrane excitability is associated with olivary hypertrophy in spinocerebellar ataxia type 1
Logan M Morrison, Haoran Huang, Hillary P Handler, et al.
Neurobiology of Disease
|
February 1, 2023
BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1
Juao-Guilherme Rosa, Katherine Hamel, Alyssa Soles, et al.
Cells
|
October 27, 2022
Spatial and Temporal Diversity of Astrocyte Phenotypes in Spinocerebellar Ataxia Type 1 Mice
Juao-Guilherme Rosa, Katherine Hamel, Carrie Sheeler, et al.
Human Molecular Genetics
|
September 23, 2020
Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1
Ravi Chopra, David D Bushart, John P Cooper, et al.
Molecular Therapy. Nucleic Acids
|
August 21, 2020
Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment
Brennon O'Callaghan, Bente Hofstra, Hillary P Handler, et al.
Cancer Research
|
June 24, 2026
Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer
Matthew A Clarke, Charlie George Barker, Ashley Nicholls, et al.
Frontiers in Genetics
|
May 19, 2025
Validation of a comprehensive long-read sequencing platform for broad clinical genetic diagnosis
Siddhartha Sen, Hillary P Handler, Alec Victorsen, et al.
Page
of 7